Amgen competitors & alternatives

Amgen Inc. is a global leader in the biopharmaceutical industry, specializing in the discovery, development, and manufacturing of human therapeutics for serious illnesses. As a pioneer in biotechnology, the company leverages advanced molecular biology and biochemistry to produce complex biologics. Professionals and stakeholders often search for competitors and alternatives to Amgen to evaluate market positioning, therapeutic pipeline strength, and manufacturing capabilities. Comparing Amgen against other industry giants helps investors and partners understand the landscape of high-value drug development, patent protection strategies, and the competitive dynamics of the global biopharmaceutical manufacturing sector.

Top Amgen competitors

Amgen competitors include Genentech, AbbVie, Gilead Sciences, Biogen and Regeneron.

12 Alternatives

Genentech

Biotechnology Research and ManufacturingEnterprise

Genentech competes with Amgen in the development of complex monoclonal antibodies and oncology therapeutics. While Amgen focuses on large-scale global manufacturing infrastructure, Genentech emphasizes early-stage clinical innovation and personalized medicine. Buyers often choose Genentech for its deep integration with Roche’s global diagnostic capabilities and specialized oncology research pipeline.

AbbVie

Biopharmaceutical DevelopmentEnterprise

AbbVie competes with Amgen in the immunology and rheumatology markets, particularly with high-value biologics. Unlike Amgen’s diversified portfolio across nephrology and bone health, AbbVie maintains a concentrated focus on blockbuster immunology franchises. Buyers may prefer AbbVie for its aggressive commercial execution and specialized expertise in managing chronic autoimmune conditions.

Gilead Sciences

Biopharmaceutical InnovationEnterprise

Gilead Sciences competes with Amgen in the development of high-impact specialty medicines, specifically in virology and oncology. While Amgen leverages a massive manufacturing footprint for biologics, Gilead focuses on small-molecule innovation and targeted viral therapies. Buyers choose Gilead for its leadership in curative treatments and highly focused therapeutic area expertise.

Biogen

Neurology-Focused BiopharmaceuticalsEnterprise

Biogen competes with Amgen in the production of complex protein-based therapies, with a specific niche in neurological disorders. Unlike Amgen’s broad-spectrum approach to chronic disease management, Biogen specializes in high-barrier-to-entry neuroscience research. Buyers often select Biogen for its deep clinical focus on multiple sclerosis and Alzheimer’s disease treatment pathways.

Regeneron

Biotechnology and Drug DiscoveryEnterprise

Regeneron competes with Amgen in the development of advanced antibody-based therapies. While Amgen utilizes established, large-scale manufacturing processes, Regeneron is known for its proprietary VelociSuite technologies that accelerate drug discovery. Buyers choose Regeneron for its rapid R&D cycle and ability to bring novel, genetically-validated targets to market faster than traditional manufacturers.

Unlock Full Company Details and Decision-Maker Insights

Tech stack categories related to Amgen

These categories group common types of tools used across the tech stack, helping organize platforms by their core capabilities.

Monoclonal Antibody Development

Research and engineering of targeted antibody therapies.

Specialty Therapeutic Pipelines

Development of high-value drugs for chronic conditions.

Biologic Drug Manufacturing

Large-scale production of complex protein-based therapeutic agents.

Market overview

The biopharmaceutical market is defined by intense competition in R&D innovation and the ability to scale complex manufacturing processes for global distribution. Key decision factors include therapeutic efficacy, patent longevity, and the ability to navigate stringent regulatory environments across international markets. Explore Amgen’s funding and financial details.

Why users choose Amgen

  • Proven track record in large-scale biologics manufacturing
  • Extensive global supply chain and distribution network
  • Strong portfolio of established chronic disease therapies
  • Significant investment in next-generation drug discovery

Why users switch to alternatives

  • Higher agility in early-stage clinical research
  • More specialized focus on niche therapeutic areas
  • Proprietary drug discovery platforms that accelerate timelines
  • Different pricing models for emerging market access

Discover competitor landscapes for other companies

China Merchants Port Group
Global Port OperatorEnterprise

China Merchants Port Group Co. Ltd is a leading global port developer and operator, specializing in container terminal management and logistics infrastructure. As a critical player in international maritime trade, the company is frequently evaluated against other global port operators and logistics giants. Businesses and investors often search for competitors and alternatives to China Merchants Port to compare terminal efficiency, geographic reach, and supply chain integration capabilities. Understanding these alternatives is essential for stakeholders looking to optimize port selection, evaluate infrastructure investment risks, or enhance global shipping connectivity through diverse terminal networks and logistics service providers.

Linsa
B2B Business ServicesEnterprise

Linsa provides specialized business services tailored to the Mexican market, focusing on operational efficiency and corporate support. As businesses seek to optimize their internal processes, they often evaluate Linsa against various competitors and alternatives to ensure they receive the best value and expertise. Whether you are looking for professional advisory, tax compliance, or strategic business consulting, comparing Linsa with industry leaders is essential for making an informed decision. This guide explores the top alternatives to Linsa, highlighting how different firms approach business services, their unique strengths, and why organizations might choose one provider over another to meet their specific operational and financial goals.

Benetton Group
Global Fashion RetailerEnterprise

Benetton Group Srl is a globally recognized fashion powerhouse known for its iconic knitwear, vibrant color palettes, and provocative marketing campaigns. Operating in the competitive apparel manufacturing and retail sector, the company balances heritage design with modern sustainability initiatives. As consumers seek alternatives, they often compare Benetton Group to other major fashion retailers that offer different balances of price, trend velocity, and brand identity. Understanding these competitors is essential for analyzing market positioning, supply chain efficiency, and consumer loyalty in the fast-paced global fashion industry. This analysis explores the top alternatives to Benetton Group, highlighting key differentiators in the retail landscape.

Cooperative Bank of Oromia
Commercial Banking ServicesEnterprise

Cooperative Bank of Oromia is a prominent financial institution in Ethiopia, specializing in cooperative-based banking, agricultural financing, and retail services. As customers seek the best financial partners, they often compare the bank against other major commercial alternatives to evaluate service reach, digital banking capabilities, and loan accessibility. Whether you are looking for specialized cooperative support or broader commercial banking features, understanding the landscape of competitors is essential. This analysis provides a clear view of how Cooperative Bank of Oromia stands against its peers, helping you identify the right banking partner based on your specific financial needs and regional requirements.

Ingram Barge
Inland Marine TransportationEnterprise

Ingram Barge Co is a leading provider of inland marine transportation services, specializing in the movement of dry and liquid bulk commodities across the U.S. inland waterway system. As a critical link in the North American supply chain, the company is frequently evaluated against other major marine logistics providers. Businesses looking for reliable alternatives often compare Ingram Barge Co to competitors based on fleet capacity, safety performance, regional coverage, and specialized cargo handling capabilities. Understanding these alternatives is essential for shippers seeking to optimize their logistics costs and ensure the secure, timely delivery of industrial goods across complex river networks.

Changsha Bank
Regional Commercial BankEnterprise

Changsha Bank Co. Ltd is a prominent regional commercial bank providing a wide range of financial services, including corporate banking, retail banking, and treasury operations, primarily serving the Hunan province. As businesses and individuals seek more specialized financial tools, many look for competitors and alternatives that offer broader digital capabilities, national reach, or advanced wealth management products. Comparing Changsha Bank against other regional commercial banks helps stakeholders identify the best fit for their specific credit, investment, and digital banking needs. This analysis evaluates how Changsha Bank stacks up against its peers in terms of service depth, technological innovation, and market positioning within the competitive Chinese banking landscape.

Frequently Asked Questions About Amgen Competitors

Who are the main competitors of Amgen?
The main competitors of Amgen include Genentech, AbbVie, and Gilead Sciences. Each competitor links to its company profile page.
What are some alternatives to Amgen?
Alternatives to Amgen include companies such as Gilead Sciences, Biogen, and Regeneron.
Which companies compete with Amgen?
Other companies that compete with Amgen include Regeneron.